|
MRI-guided prostate brachytherapy dose escalation to the dominant intraprostatic lesions: A retrospective analysis of urinary toxicity and biochemical response. |
|
|
Honoraria - Abbvie; Ferring; Janssen; Sanofi; TerSera |
Consulting or Advisory Role - Abbvie; Ferring; Janssen; Sanofi |
|
|
No Relationships to Disclose |
|
|
|
Consulting or Advisory Role - Ferring |
|
|
Stock and Other Ownership Interests - Janssen |
Honoraria - Abbvie; Janssen; Sanofi |
Consulting or Advisory Role - Abbvie; Janssen; Sanofi |
Speakers' Bureau - Ferring; Janssen |
Research Funding - Astellas Oncology; Janssen |
|
|
Consulting or Advisory Role - Janssen |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Abbvie; Sanofi; TerSera |
|
|
|
|
|
Consulting or Advisory Role - Abbvie; Ferring; Sanofi |
Speakers' Bureau - Abbvie; Ferring; Sanofi |
Research Funding - Abbvie |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |